Use this URL to cite or link to this record in EThOS:
Title: Pre-clinical and clinical evaluation of apoptosis targeting drugs
Author: Dean , Emma
Awarding Body: University of Manchester
Current Institution: University of Manchester
Date of Award: 2009
Availability of Full Text:
Access from EThOS:
Lung cancer is the leading cause of cancer deaths amongst both men and women and is commonly divided into two histological groups, non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Despite advances in early diagnosis and treatment, chemotherapy provides poor response rates and rare complete remissions, warranting the development of novel therapeutic strategies. Evasion of apoptosis is a hallmark of cancer, allowing malignant cells to survive in hostile micro-environments and to resist chemotherapy with the potential for continued proliferation. This thesis evaluates four novel agents, primarily in lung cancer, in both the pre-clinical and early clinical settings which target key molecules involved in the regulation of apoptosis. Pre-clinical data for XAC 1396-11, a small molecule inhibitor of X-linked inhibitor of apoptosis protein (XIAP), showed induction of apoptotic cell death in a concentration- and time-dependent manner in NSCLC cells.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available